找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Resistant Hypertension in Chronic Kidney Disease; Adrian Covic,Mehmet Kanbay,Edgar V. Lerma Book 2017 Springer International Publishing AG

[復(fù)制鏈接]
樓主: energy
21#
發(fā)表于 2025-3-25 06:07:36 | 只看該作者
Resistant Hypertension in Elderly People with Chronic Kidney Disease,deed, around 60% of those aged 80 years or older have chronic kidney disease. Thus, population studies in such elderly individuals probably reflect individuals with chronic kidney disease. During aging both systolic blood pressure and pulse pressure progressively increase. It is important to note th
22#
發(fā)表于 2025-3-25 10:00:14 | 只看該作者
Obstructive Sleep Apnea and Resistant Hypertension,everal factors, including obesity, are common to both disorders, a large body of evidence accumulated over several years supports OSA as having an independent and causal role in precipitating and perpetuating hypertension..Both OSA and resistant hypertension are associated with increased cardiovascu
23#
發(fā)表于 2025-3-25 12:55:16 | 只看該作者
24#
發(fā)表于 2025-3-25 19:30:40 | 只看該作者
Public Health Efforts for Earlier Resistant Hypertension Diagnosis, Reduction of Salt Content in Fo being a diuretic at full doses, blood pressure remains uncontrolled. Firstly, it should be confirmed that the patients with resistant hypertension do have true RHT; this can be done by ruling out or correcting factors associated with pseudo-resistance which contain an inaccurate measurement of bloo
25#
發(fā)表于 2025-3-25 23:27:51 | 只看該作者
Treatment of Hypertension in Light of the New Guidelines: Salt Intake,cally rises with decline in kidney function, and sustained elevations in BP hasten progression of kidney disease. Hypertension in patients with CKD is often accompanied by a decrease in the kidney’s ability to remove salt. Addressing this salt sensitivity is critical for the management of HT in CKD
26#
發(fā)表于 2025-3-26 03:49:14 | 只看該作者
27#
發(fā)表于 2025-3-26 07:21:56 | 只看該作者
Treatment of Hypertension in Light of the New Guidelines: Pharmacologic Approaches Using CombinatioD), since these patients have usually been excluded from randomized controlled trials (RCTs) in hypertension. Combined therapy, however, has to be individualized, depending on the patient’s pathophysiologic profile, comorbidities, and contraindications. The optimal combination should be well tolerat
28#
發(fā)表于 2025-3-26 12:33:29 | 只看該作者
Devices for Neural Modulation (Renal Denervation, Barostimulation),m (SNS). Kidneys are innervated by two types of fibers the sensory afferent fibers leading from the central nervous system to the kidneys and sympathetic efferent fibers which start in the kidneys and run to the central nervous system. Results of experimental and clinical studies suggest that affere
29#
發(fā)表于 2025-3-26 14:56:19 | 只看該作者
30#
發(fā)表于 2025-3-26 19:03:57 | 只看該作者
Treatment of Hypertension in Light of the New Guidelines: Salt Intake,and dietary salt restriction and appropriate diuretic therapy make up the mainstay of HT treatment in patients with CKD. This chapter reviews the importance of salt in pathogenesis and maintenance of HT in CKD and the role of salt restriction in controlling HT in CKD.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 18:10
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
恩平市| 郎溪县| 屏山县| 平乡县| 贞丰县| 利川市| 聂拉木县| 宁陵县| 陕西省| 得荣县| 潞西市| 黄平县| 松滋市| 玉山县| 马鞍山市| 牙克石市| 温州市| 扬州市| 和顺县| 日喀则市| 京山县| 东阳市| 临沧市| 江西省| 桃园县| 成都市| 友谊县| 云浮市| 英超| 通州市| 景宁| 杭锦旗| 洛阳市| 丰都县| 西安市| 中山市| 崇州市| 贺州市| 道孚县| 万州区| 南宁市|